Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Risk Assessment/Risk Management Commission

This article was originally published in The Tan Sheet

Executive Summary

Risk Assessment/Risk Management Commission: Final report from 10-member Presidential/Congressional commission released March 7. Unchanged from a June draft, the report says that FDA's ability to require scientific evidence from dietary supplement manufacturers in support of health claims has suffered under the Dietary Supplement Health & Education Act and "should be reaffirmed and strengthened" ("The Tan Sheet" June 17, 1996, p. 18). Council for Responsible Nutrition Director of Scientific & Regulatory Affairs Annette Dickenson, PhD, had testified to the commission in July that DSHEA is not a threat to FDA's authority over dietary supplements ("The Tan Sheet" July 29, 1996, p. 4)...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS086785

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel